Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 280 (5367), 1268-70

Aspirin-like Molecules That Covalently Inactivate cyclooxygenase-2

Affiliations

Aspirin-like Molecules That Covalently Inactivate cyclooxygenase-2

A S Kalgutkar et al. Science.

Abstract

Many of aspirin's therapeutic effects arise from its acetylation of cyclooxygenase-2 (COX-2), whereas its antithrombotic and ulcerogenic effects result from its acetylation of COX-1. Here, aspirin-like molecules were designed that preferentially acetylate and irreversibly inactivate COX-2. The most potent of these compounds was o-(acetoxyphenyl)hept-2-ynyl sulfide (APHS). Relative to aspirin, APHS was 60 times as reactive against COX-2 and 100 times as selective for its inhibition; it also inhibited COX-2 in cultured macrophages and colon cancer cells and in the rat air pouch in vivo. Such compounds may lead to the development of aspirin-like drugs for the treatment or prevention of immunological and proliferative diseases without gastrointestinal or hematologic side effects.

Comment in

Similar articles

See all similar articles

Cited by 35 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback